Function and efficacy of Lorlatinib
Loratinib is a targeted therapy drug for a specific type of lung cancer. Its main component is an anaplastic lymphoma kinase (ALK) inhibitor. It is mainly used to treat locally advanced or metastatic non-small cell lung cancer that is ALK-positive (a specific gene mutation) or has spread to other parts of the body.
What diseases can Lorlatinib be used to treat?
Loratinib is administered orally once daily and is specifically used to treat ALK-positive locally advanced or metastatic non-small cell lung cancer. This drug effectively controls tumor growth and spread by inhibiting the activity of ALK kinase (an enzyme crucial for cancer cell growth). Clinical studies have shown that proper use of this drug can help prolong patient survival.
What symptoms can loratinib relieve?
During treatment with loratinib, the drug can help relieve the following symptoms by controlling tumor growth and spread:
Breathing problems caused by tumors compressing or invading the airways, such as difficulty breathing or shortness of breath, or a cough that cannot be relieved for a long time.
Chest pain caused by a tumor invading the chest wall or lung tissue.
Other physical discomforts caused by the space-occupying effect of tumors.
